TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novavax AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
524,647
|
820,346
|
1,570,987 |
| Financial expenses |
51,385
|
680,115
|
772,273 |
| Earnings before taxes |
260,275
|
194,900
|
518,188 |
| EBITDA |
141,064
|
223,770
|
536,993 |
| Total assets |
2,654,994
|
3,615,737
|
3,747,809 |
| Current assets |
137,369
|
205,513
|
2,637,429 |
| Current liabilities |
131,063
|
1,318,942
|
1,661,167 |
| Equity capital |
2,522,546
|
2,296,795
|
2,086,642 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
173
|
195
|
167 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
95.0%
|
63.5%
|
55.7% |
| Turnover per employee |
3,033
|
4,207
|
9,407 |
| Profit as a percentage of turnover |
49.6%
|
23.8%
|
33.0% |
| Return on assets (ROA) |
11.7%
|
24.2%
|
34.4% |
| Current ratio |
104.8%
|
15.6%
|
158.8% |
| Return on equity (ROE) |
10.3%
|
8.5%
|
24.8% |
| Change turnover |
-295,699
|
-750,641
|
590,096 |
| Change turnover % |
-36%
|
-48%
|
60% |
| Chg. No. of employees |
-22
|
28
|
167 |
| Chg. No. of employees % |
-11%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.